A potential game-changer in blood and marrow transplantation
By N. G. Boeck / For Fred Hutch News Service
Researchers at Fred Hutch Cancer Center are studying whether a lower dose of post-transplant cyclophosphamide could help prevent graft-versus-host disease while reducing treatment-related side effects. This promising work may help improve recovery, immune function, and quality of life for future blood and marrow transplant patients.
On Purpose, For Purpose: Why I Advocate
By Amanda Brunson
After facing leukemia twice and undergoing a bone marrow transplant, Amanda Brunson learned that surviving cancer is only part of the journey. Rebuilding a life afterward can bring challenges of its own, especially for young adults navigating changes in identity, relationships, health, fertility, and the future. In this deeply personal reflection, Amanda shares how those experiences shaped her commitment to advocacy and inspired her to use her voice, her story, and the life she fought to keep to help make the path a little easier for others.